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Vascular cells are an important arget for gene transfer because of their potential to 
deliver gene products both locally and systemically. Direct retroviral gene transfer to 
vascular cells in vivo has been limited by inefficient rates of  transduction. We hypothe- 
sized that vascular cell transduction efficiency (TE), during short retroviral incubation 
periods, is significantly improved in vitro and in vivo using centrifugation to increase 
viral titer. Furthermore, we hypothesized a linear relationship between concentration of  
viable viral particles (measured as colony-forming units (CFUs)/cell) and retroviral TE 
during short incubation periods. Cultured rat pulmonary artery endothelial cells 
(RPAECs), rat aortic smooth muscle cells (RSMCs), and human iliac artery endothelial 
cells (HIAECs) demonstrated a strong correlation between TE and high concentrations 
of  virus (>100 CFU/ceI1) during retroviral incubation periods of  10 to 60 minutes. 
High titers, and thereby high concentrations, were achieved by centrifugation and 
resuspension i a fraction of  the original volume. Titer was consistently increased tenfold, 
for a twentyfold increase in concentration by volume. A 20-minute incubation with a 
Moloney murine leukemia-derived retroviral vector coding for human placental alkaline 
phosphatase, pLJhpAP, at a concentration of  1150 CFU/cel l  yielded TEs of  10.6% + 
0.7%, 40.4% --. 1.6%, and 15.1% _ 2.0% for RPAECs, RSMCs, and HIAECs, respectively. 
A similar effect was shown using the Moloney murine leukemia-derived MFGIacZ 
retroviral vector, coding for Escherichia coli B-galactosidase. Increased titer and concen- 
tration had no effect on target cell viability, as shown by trypan blue exclusion. Although 
RSMCs had the most cells transduced in a given incubation period (p < 0.05), RPAECs 
had the highest replication rate (p < 0.05), suggesting the importance of factors other 
than cell cycle on retroviral TEs during short, clinically relevant incubation periods. In 
subsequent in vivo experiments, gene transfer was achieved in the rat carotid artery 
during a 20-minute incubation period infusing the concentrated pLJhpAP retrovirus 
after carotid balloon injury. Rats infused with virus 2 days after balloon injury exhibited 
hpAP activity (0 to 10 cells/section/rat) in the neointima of  five out of  six rats. Rats 
infused 4 days after balloon injury exhibited hpAP activity (0 to 25 cells/section/rat) in
the media and adventitia of  five out of  five rats. Control rats that received the balloon 
injury alone or the balloon injury and tmconcentrated retrovirus exhibited zero hpAP 
activity. We Conclude that the TE of  retroviral-mediated gene transfer to vascular cells in 
vitro and in vivo can be improved during short, clinically relevant incubation periods 
using centrifugation to increase retroviral titer, and thereby concentration of viable viral 
particles. (J Vase Surg 1997;26:119-27.) 
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There are many advantages to the use of replica- 
tion-incompetent re roviral vectors for gene transfer: 
stable integration of the recombinant gene carried by 
the vector into the host genome, lack of vector ep- 
lication or production of viral proteins after trans- 
duction, and lack of apparent toxicity to target cells.1 
However, the potential use of retroviral vectors for 
direct gene transfer in vivo has been limited by inef- 
ficient transduction of target cells. Several methods 
to increase transduction efficiency (TE) of retroviral 
vectors have been explored, including increasing du- 
ration or frequency of exposure to retrovirus, 24 
coculturing of target cells with retroviral producer 
cells, a optimization of the polycation retroviral ad- 
junct, 3and techniques, uch as centrifugation 3,s and 
genetic engineering ofretroviral vectors, 6 to improve 
retroviral titer. However, success with these strate- 
gies has been limited and variable. In addition, with 
the exception of increasing retroviral titer, all meth- 
ods have limitations in their application to direct 
gene transfer in vivo. Thus establishing a consistent, 
clinically relevant means of elevating TE remains 
essential to realizing the potential of direct, retrovi- 
ral-mediated gene transfer in vivo. 
Recently, the blood vessels have been identified 
as being excellent targets for gene transfer because of 
their interface with the circulating blood and, thus, 
their ability to deliver a recombinant gene product 
both systemically and locally. 7,8 Unfortunately, the 
retroviral TEs of vascular endothelial cells have been 
shown to be particularly low, 1% to 15% s in vitro 
after a 6-hour incubation period, and much lower in 
v ivo .  9'1° Transduction of vascular smooth muscle 
cells in vivo has been similarly inefficient, ll Another 
limit to the techniques of direct gene transfer in vivo 
is the relatively short durations of vessel occlusions 
that can be used for genc transfer without causing 
tissue ischemia nd reperfusion i jury. Clearly, strat- 
egies designed to increase retroviral TEs of vascular 
cells during short, clinically relevant transduction pe- 
riods would be an important step to realizing the 
potential of direct retroviral-mediated gene transfer 
to the vessel wall in the treatment ofdiseases such as 
restenosis after balloon angioplasty. 
In the present study, we hypothesized that TE of 
retroviral-mediated gene transfer to vascular cells 
during short, clinically relevant incubation periods 
would be significantly improved in vitro and in vivo 
using centrifugation to increase viral titer and 
thereby concentration of viable viral particles. Fur- 
thermore, we hypothesized that a linear correlation 
between concentration and retroviral TE exists 
among vascular cells during such short, clinically 
relevant incubation periods in vitro. Previous studies 
that examined the relationship between concentra- 
tion and TE during longer 6-hour incubations 
showed only marginal increases in TE when concen- 
tration was raised by concentration fviral superna- 
tant. It was concluded that during these longer 
6-hour incubations concentration of viral superna- 
tant was not a practical means by which to increase 
TE of endothelial cells. 3 In contrast, during short, 
clinically relevant incubation periods, the effects of 
concentrating viral supematant have been found to 
significantly increase the TE of endothelial cells. 
Thus our study not only establishes a strategy to 
increase the retroviral TE of vascular cells, but does 
so without sacrificing its applicability to clinical 
needs. 
MATERIALS AND METHODS 
Cell culture. A previously characterized, im- 
mortalized rat pulmonary artery endothelial cell 
(RPAEC) line 12 was grown in high glucose Dulbec- 
co's modified Eagle's medium (DMEM; Gibco, 
Gaithersburg, Md.) with 10% fetal bovine serum 
(FBS; Hyclone Laboratories Inc., Logan, Utah), 100 
U/ml penicillin (Gibco), 100 txg/ml streptomycin 
(Gibco), and 4 I~mol/L L-glutamine (Gibco). Rat 
smooth muscle cells (RSMCs) were enzymatically 
harvested from thoracic aortae of adult Sprague- 
Dawley rats as previously described) 3 The study was 
approved by the Institutional Review Board and the 
animal care complied with the Guide of the Care and 
Use of Laboratory Animals, Institute of Laboratory 
Animal Resources, Commission of Life Sciences, 
National Research Council. Washington: National 
Academy Press, 1996. Confirmation of smooth 
muscle identity was performed by immunofluores- 
cent detection of smooth muscle cell-specific alpha 
actin (HHF-35, monoclonal antibody). RSMCs 
were grown in low-glucose DMEM supplemented 
with 10% FBS, I00 U/ml  penicillin, 100 Ixg/ml 
streptomycin, and 4 I~mol/L L-glutamine. Hu- 
man iliac artery endothelial cells (HIAECs) were 
enzymatically derived from the human iliac artery 
of healthy transplant donors. The vessel segment 
was incubated for 20 minutes with 40 U/ml  dis- 
pase (Boehringer Mannheim, Indianapolis, Ind.) 
at pH 7.15 and 37 ° C. The dispase fraction was 
collected and the vessel flushed with M-199 
(Gibco). These fractions were then centrifuged 
and resuspended in growth media consisting of 
M-199, 20% FBS, 100 U/ml  penicillin, 100 
Ixg/ml streptomycin, 4 ~mol/L  L-glutamine, 50 
Ixg/ml endothelial cell growth supplement 
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ECGS; Collaborative Research, Bedford, Mass.), 
and 15 U/ml heparin (Sigma Chemical Co., St. 
Louis). Endothelial cell suspensions were then placed 
into gelatin-coated (Sigma) T25 tissue culture flasks 
(Costar, Cambridge, Mass.). Confirmation of endo- 
thelial cell identity was performed by the presence of 
von Willebrand's factor and the ability to take up 
diacetylated LDL. 14 All cell lines were cultured in a 
humidified incubator (37 ° C, 5% CO2) and passaged 
when appropriate after a 5-minute xposure to 0.5% 
trypsin-ethylenediamine tetraacetic a id (Gibco) us- 
ing standard tissue culture techniques, NIH 3T3 
fibroblasts used for titering assays were grown in 
high-glucose DMEM containing 10% BCS, 100 
U/ml penicillin, 100 jxg/ml streptomycin, and 4 
ixmol/L L-glutamine. 
Recombinant retroviral vectors. The replica- 
tion-incompetent re roviral vector used in the ma- 
jority of these experiments (unless indicated) was 
pLJhpAP, the construction and characterization f 
which has been described previously. 15This retrovi- 
ms contains the eDNA for the heat-stable human 
placental alkaline phosphatase (hpAP) marker gene, 
driven by the Moloney murine leukemia virus long 
terminal repeat (MMLV-LTR), and the neomycin 
phosphotransferase gene driven by an internal simian 
virus 40 (SV40) promoter. The YCRIP pLJhpAP 
packaging cell line consistently produced a titer of 
2.9 × 10 7 G418-resistant colony-forming units 
per milliliter (CFU/ml) as measured by its ability 
to transfer G418-resistance to 3T3 fibroblasts. 16
MFGlacZ, the construction and characterization 
of which has also been previously described, 17was 
the second replication-incompetent r trovirus used. 
This retrovirus contains the gene for Escherichia coil 
[3-galactosidase transcribed off the MMLV-LTR and 
does not contain agene for neomycin resistance. The 
YCRIP MFG-lacZ packaging cell line produced this 
retrovirus at a titer of 1 × 105 CFU/ml as deter- 
mined by X-gal staining of MFGlacZ-transduced 
3T3 fibroblasts. 
Procedure for increasing retroviral titer. Ten 
milliliters of 3T3 media was repeatedly harvested 
from pl00 cell culture plates after a 12-hour expo- 
sure to YCRIP pLJhpAP or YCRIP MFGIacZ retro- 
viral packaging cells and filtered through a 0.45 txm 
filter. This "retroviral supernatant" was centrifuged 
in 50 ml polypropylene c ntrifuge tubes in a Beck- 
man J2-21 centrifuge (15,000g for 90 minutes at 
4 ° C). Subsequently, the supernatant was decanted, 
and the retroviral particles were resuspended in 0.5 
ml of 3T3 media (5% original volume) for every 10 
ml of the "retroviral supernatant" that was harvested. 
This procedure typically raised the titer (measured as 
CFU/ml) tenfold (data not shown). 
In vitro transduction experiments. RPAECs, 
RSMCs, or HIAECs were plated at 10,000 cells/ 
cm 2, 20 ,000  cells/era 2, and 20,000 cells/cm 2, re- 
spectively, into 24-well plates (Costar). RPAECs 
were allowed to adhere for 24 hours before retroviral 
transduction. RSMCs and HIAECs were cultured for 
48 hours before retroviral transduction. All cell lines 
were exposed to retroviral supernatants at varying 
titers in the presence of 40 ~g/ml polybrene (Sig- 
ma). The titer was varied by altering the concentra- 
tion of viral particles per unit volume (as described 
above). Concentration of viable viral particles was 
then calculated as (titer) × (transduction volume)/ 
(no. of cells exposed to retrovirus) and thus mea- 
sured as CFUs/cell. The concentration was varied by 
adjusting the effective titer (measured CFU/ml) per 
number of cells (counted in parallel wells). Two sets 
of controls were done, exposing the cells to uncon- 
centrated virus or to 3T3 media, both in the presence 
of 40 txg/ml polybrene. After various experimental 
incubation periods, cells were rinsed twice with 3T3 
media (to ensure termination of the incubation pe- 
riod) and then grown in their respective medias for 
36 to 48 hours to allow integration, transcription, 
and translation of the eDNA of interest. Subse- 
quently, cells were fixed and stained for hpAP or 
lacZ. Staining was used to quantitate the number of 
transduced cells per high power field. TE was deter- 
mined to be the number of stained cells to total cells 
(stained and unstained) per high power field. 
Parallel wells were treated[ similarly and incubated 
with 0.05% trypan blue (Sigma) immediately after 
transduction to determine the effect of incubation 
with retroviral supernatant a high viral concentra- 
tions on cell viability, 
Parallel wells were also used for cell counts, using 
an automated cell counter (Coulter Electronics, Hi- 
aleah, Fla.) or for 3H-thymidine incorporation to 
determine relative replication rates at the times of 
retroviral transduction. After' a 1-hour incubation i  
3H-thymidine (2 ~tCi/well), trichloroacetic a id pre- 
cipitable extracts were counted in a scintillation 
counter. Counts per minute (cpm) were normalized 
to the number of cells present for each cell type. 
In vitro histochemical staining procedures. 
Thirty-six to forty-eight hours after transduction, 
cells incubated with pLJhpAP retrovims were 
washed in phosphate-buffered saline solution (D- 
PBS, Gibco) and were fixed in 2% formaldehyde and 
0.2% glutaraldehyde in PBS at 4 ° C for 5 minutes. 
Cells were subsequently rinsed twice in PBS and 
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Fig. 1. Effect of using concentrated retroviral superna- 
tant on TE of RPAECs using two vectors, pLJhpAP and 
MFGlacZ. Cells were exposed to concentrated or uncon- 
centrated pLJhpAP or MFGlacZ retroviral supernatant 
with 40 I*g/ml polybrene 24hour after plating. Cells were 
fixed and stained for hpAP or lacZ activity 48 hours later. 
Data represent a percent of unconcentrated controls, are 
expressed as a mean (n = 3 high power fields per condi- 
tion), and are representative of three similar experiments. 
incubated at 65 ° C for 30 minutes to heat inactivate 
endogenous alkaline phosphatase activity. After this 
incubation, cells were rinsed in PBS and incubated 
at 37 ° C in 100 mmol /L  Tris-HCl (pH 10.0) and 
1 mg/ml  5-Bromo-4-chloro-3-indolylphosphate p- 
toluidine salt (Gibco) in PBS until purple staining, 
indicative of hpAP activity, was observed (1 to 8 
hours). 18 Forty-eight hours after transduction with 
MFGlacZ retrovirus, cells were washed in PBS, fixed 
in 0.5% glutaraldehyde in PBS at room temperature 
for 5 minutes, and subsequently rinsed twice in PBS. 
Cells were then incubated in 1 mol /L  Tris-HC1, 50 
mmol /L  ferriferrocyanide, 5 mol /L  NaC1, 1 mol /L  
MgCI2, 40 mg/ml  X-gal (5-Bromo-4-chloro-3-in- 
doly-J~-D-galactosidase) in PBS at 37 ° C until blue 
staining, indicative oflacZ activity, was observed (18 
hours). 19 
Rat carotid bal loon injury and retroviral incu- 
bation. In brief, male Sprague-Dawley rats (300 to 
350 g) were anesthetized, and the left carotid artery 
was surgically exposed. The proximal common ca- 
rotid artery and distal internal arteries were clamped. 
After ligation of the distal external carotid artery, a 
2F balloon catheter was inserted through a small 
arteriotomy. After three passages of the balloon, the 
external carotid artery was ligated just proximal to 
the arteriotomy, the clamps were removed (restoring 
blood flow), and the wound was closed. 2° Two or 4 
days later, the rats were reanesthetized and the left 
carotid artery was reexposed. Clamps were placed on 
the proximal common carotid artery and on the dis- 
tal internal carotid artery. On the external branch, 
the ligature proximal to the arteriotomy was re- 
moved, a cannula was inserted into the arteriotomy, 
and residual blood in the isolated segment of the 
carotid artery was flushed out with saline solution. 
Retroviral transduction was carried out using 100 ~1 
of concentrated pLJhpAP retrovirus (8.8 × 109 
CFU/ml)  with 40 >g/ml  polybrene for 20 minutes. 
This incubation period was followed by religation of 
the external branch proximal to the arteriotomy and 
reestablishing flow to the common carotid artery by 
removing temporary proximal and distal clamps. 
Two days after transduction, the rats were again 
anesthetized and the carotid artery was flushed and 
perfusion-fixed (120 mm Hg) with 10% formalde- 
hyde in PBS via the abdominal aorta. The carotid 
artery, from the arteriotomy site to the aortic arch, 
was removed and placed in 10% formaldehyde. 
Twenty-four hours later, the tissues were transferred 
to 70% ethanol until they were paraffin-embedded 
and sectioned for histologic staining. Histologic sec- 
tions were then stained separately with hematoxylin 
and eosin or for localization of  hpAP as previously 
described. 21 
Statistical analysis. All data are expressed as the 
mean plus or minus the standard error of the mean 
(SEM). The statistical analysis was performed using 
analysis of variance and a post hoc comparison be- 
tween groups within Fisher's protected least squares 
difference test or a two-tailed t test, where appropri- 
ate. 22 Significance was assigned when the p value was 
less than 0.05 (Statview 4.0, Abacus Concepts, Inc., 
Berkeley, Calif.). 
RESULTS 
Effect of  centrifugation on viral titer and TE. 
Elevation of pLlhpAP retroviral titer by centrifuga- 
tion and resuspension i 5% of its original volume 
consistently resulted in a one log increase in titer, 
measured in a standard titering assay on 3T3 cells as 
CFU/ml  (data not shown). In addition, retrovirus 
that underwent the centrifugation and resuspension 
process consistently produced higher TE. A 20- 
minute incubation with RPAECs resulted in a five- 
fold higher TE than that of control cells exposed to 
unconcentrated viral supernatant (5.4% + 0.72% vs 
1.01% .+ 0.35%; p < 0.05). To determine whether 
this effect was reproducible on RPAEC using other 
retroviral vectors, a similar experiment was designed 
using the MFGIacZ retrovirus. In this experiment, a 
similar sixfold increase in TE was observed (0.34% + 
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Fig. 2. Effect of duration of concentrated retroviral expo- 
sure on TE. Cells were exposed to concentrated pLJhpAP 
retroviral supernatant 24 hours (RPAECs) and 48 hours 
(RSMCs, HIAECs) after plating for incubation periods of 
10, 20, 40, or 60 minutes. Cells were fixed and stained for 
hpAP activity 36 to 48 hours later. Data are expressed as 
mean -+ SEM (n = 3 high power fields per condition) and 
are representative of three similar experiments. *p < 0.05 
vs 10 minute RSMC. **p < 0.05 vs 10 minute HIAEC. 
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Fig. 3. Effect of MOI on TE during short, 20-minute 
incubation periods. Experiments were performed as de- 
scribed in Fig. 2, with MOI being calculated as (titer) 
(feeding volume)/(no, of cells exposed), and elevated by 
increasing titer through centfifugation a d resuspension as
described in "Methods" section. Data are expressed as 
mean _+ SEM (n = 3 high power fields per condition) and 
are representative of three similar experiments. 
0.14% vs 0.05% + 0.05%;p < 0.05). In addition, the 
efficacy and reproducibility of  this technique to im- 
prove TE was assessed on two other types of  vascular 
cells, RSMCs and HIAECs. TE was increased five- 
fold in RSMCs (14.2% + 1.40% vs 2.84% + 0.17%; 
p < 0.05) and threefold in HIAECs (13.1% + 1.32% 
vs 3.8% + 0.05%;p < 0.05; Fig. 1). 
Effect o f  the centr i fugation process itself. To 
confirm that the improved TE seen after centrifuga- 
tion and resuspension was a result of  concentrating 
the retrovirus, as opposed to an unknown benefit of  
the centrifugation process itself, an experiment was 
designed to compare the exposure of RPAECs to 
pLJhpAP retroviral supernatant that was not centri- 
fuged to retroviral supernatant that was centrifuged 
and resuspended in 100% or 5% of  the original vol- 
ume. The RPAECs exposed to retrovirus, centri- 
fuged, and resuspended in 100% original volume 
failed to exhibit a significant increase in TE over 
noncentrifuged retrovirus controls (1.69% + 0.25% 
vs 1.93% + 0.23%). The RPAECs exposed to retro- 
viral supernatant, centrifuged, and resuspended in 
5% original volume again demonstrated a significant 
fivefold increase in TE (10.63% + 0.38%; p < 0.05). 
Effect o f  durat ion o f  exposure on TE o f  con- 
centrated retroviral supernatant.  To determine 
whether the duration of exposure to concentrated 
retroviral supernatant was an important factor within 
short, clinically feasible incubation periods, RPAECs, 
RSMCs, and HIAECs were exposed to centrifuged 
pLJhpAP retrovirus for transduction periods less 
than 60 minutes (Figl 2). Increasing transduction 
periods resulted in a gradual increase in TE over time 
for all cell lines. This increase achieved statistical 
significance for the RSMC and HIAEC lines only. 
Effect o f  frequency o f  exposure on TE o f  con- 
centrated retroviral supernatant.  As a result of  the 
success of  using concentrated retroviral supernatants 
to achieve high TEs during incubation periods as 
short as 10 minutes and the failure to increase TE 
consistently and significantly with increased uration 
of exposure, an experiment was designed to examine 
the effect of concentrated retroviral supernatant ex- 
posure frequency on TE. RPAECs were exposed to 
concentrated retroviral supernatant for 10 minutes, 
30 minutes, or three consecutive times for 10 min- 
utes. On staining for hpAP and counting the number 
of cells transduced, no statistically significant differ- 
ence was observed between the three conditions. 
Effect o f  concentrat ion o f  viral particles on 
TE. Some relationship between multiplicity of  in- 
fection (MOI) and retroviral TE has previously been 
observed uring relatively long incubation periods (6 
hours). 3 This relationship, however, showed that TE 
reached aplateau at a relatively low concentration (2
CFU/cel l)  and decreased from a linear relation with 
respect o concentration between 2 and 100 CFU/  
cell. Experiments in our study were designed to de- 
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Fig. 4. Histologic examination of TEs achieved in vascular cells during a short, clinically 
relevant 20-minute incubation period using high MOIs. A, Heat-stable alkaline phosphatase 
staining (purple) indicative ofhpAP activity among RPAECs after a 20-minute incubation with 
pLJhpAP retroviral supernatant (at an MOI of 1169) 48 hours after transduction (original 
magnification, 200 ×). B, Heat-stable alkaline phosphatase staining (purple) indicative of hpAP 
activity among RSMCs after a 20-minute incubation with pLJhpAP retroviral supernatant (at an 
MOI of 1169) 36 hours after transduction (original magnification, 100 × ). 
termine whether there was a relationship between 
retroviral TE and higher concentration (highest con- 
centration was 1150 CFU/cell) during a shorter, 
more clinically relevant incubation period. A consis- 
tent, direct relationship between retroviral TE and 
concentration was demonstrated for all cell lines dur- 
ing this short, 20-minute incubation period over a 
range of concentrations (Fig. 3). The two types of 
vascular endothelium, RPAECs and HIAECs, dem- 
onstrated statistically different TEs (10.63% + 1.73% 
vs 15.10% + 2.02%; p < 0.05) at the highest concen- 
tration tested. RSMCs had a TE at the highest con- 
centration (40.40% _+ 1.64%; p < 0.05) that was 
almost fourfold higher than that of the RPAECs and 
almost threefold higher than that of the HIAECs 
(p < 0.05; Fig. 4, A and B). 
To determine whether this difference in TE was a 
result of differences in rates of cell proliferation, 3H- 
thymidine incorporation was performed at the time 
of transduction for each of the three cell lines as a 
measure of proliferation rate (Fig. 5). The RPAECs, 
despite consistently having the lowest TE, demon- 
strated a rate of thymidine uptake that was fourfold 
and sevenfold higher than that of the RSMCs and 
HIAECs, respectively, indicating that concentration 
is an important predictor of TE during short incuba- 
tion periods. Concentration did not have an effect on 
cell viability, as determined by trypan blue exclusion 
(data not shown). 
Direct gene transfer into rat balloon-injured 
carotid artery using concentrated retrovirus. Be- 
cause of the variable results previously achieved with 
direct retroviral-mediated gene transfer using retro- 
virus into the arterial wall in vivo, 1°,11 concentrated 
retroviral supernatant (8.8 × 109 CFUs/ml) was 
introduced into the rat carotid artery at times when 
neointimal cells are known to be proliferating after 
balloon injury, n,2° Rats that were infused with the 
concentrated pLJhpAP retrovirus 2 days after bal- 
loon injury and killed 2 days after retroviral infusion 
exhibited positive staining in five out of six rats. This 
hpAP activity (0 to 10 cells/section/rat) was found 
mostly in the neointima (Fig. 6, A). Rats that were 
infused with concentrated pLJhpAP retrovirus 4 days 
after balloon injury and ldlled 2 days after retroviral 
infusion exhibited positive staining in five out of five 
rats. This hpAP activity (0 to 25 cells/section/rat) 
was localized mostly in the media and adventitia (Fig. 
6, D). Of interest to future studies, the positive hpAP 
staining commonly appeared localized to one region 
of the vessel (Fig. 6, D), possibly as a result of a 
"settling" effect of the viral particles. Control vessels 
for the injury (hematoxylin and eosin) and those 
infused with unconcentrated retrovirus (stained for
hpAP) 2 days after balloon injury (Fig. 6, B and C) 
and 4 days after balloon injury (Fig. 6, E and /~ 
showe.d zero hpAP-positive cells. 
DISCUSSION 
Direct, retroviral-mediated gene transfer in vivo 
to tissues other than the regenerating liver has been 
limited by low TE, particularly in vascular cells. 3,23,24 
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Studies have improved on this low TE by extending 
the duration of exposure to the retrovirus to periods 
as long as 6 to 12 hours. The rationale behind this 
strategy has been that a greater number of actively 
replicating target cells will be in the mitotic phase of 
the cell cycle that is necessary for rctroviral-mediated 
gene transfer, while being exposed to the retroviral 
supernatant. 3,25 TEs from 10% to 25% have been 
shown for endothelial cells with a 6-hour exposure to 
retrovirus. 3 The limitation of this strategy, however, 
is apparent when considering a model for direct in 
vivo retroviral-mediated gene transfer. Clearly, a 
6-hour exposure to retrovirus i not clinically feasible 
during therapeutic vascular interventional or open 
procedures. Furthermore, the present study suggests 
that the number of mitotic cells is not the only 
predictor of TE during clinically applicable incuba- 
tion periods of less than 1 hour. Within an incuba- 
tion range of  10 to 60 minutes, the TE was not 
consistently and significantly elevated (Fig. 2). In 
addition, the RPAECs, which had the highest prolif- 
erative rate, had a lower TE for a given MOI than the 
RSMCs (Fig. 5). 
Another strategy to increase TE has been to in- 
crease concentration of the polycation. Although in- 
creased concentrations of polybrene and other poly- 
cations have been shown to increase vascular cell 
TEs, this technique has significant limitations be- 
cause polycations erve to injure the target cell's 
membrane, which results in decreased cell viability. 3
The experiments presented in this study used a consis- 
tent polybrene concentration (40 txg/rnl) over a wide 
range of concentrations of viable viral particles; these 
high concentrations had no significant effect on cell 
viability when compared with nontransduced controls. 
Improvement of  vascular cell retroviral TE in a 
manner that focuses on the requirement for an effi- 
cient, direct in vivo gene transfer application is im- 
portant o future clinical applications of this technol- 
ogy. Strategies to improve TE by increasing the 
retroviral titer and viral particle concentration are 
shown in this study to be one such option. Centrifu- 
gation ofrctroviral supernatant clearly serves to dem- 
onstrate that elevated titer, and thus concentration, 
can increase TE within clinically feasible time peri- 
ods. The previously unrecognized relationship be- 
tween the concentration ofviable retroviral particles 
and the TE of vascular cells is critical to future inves- 
tigations designed to increase levels of in vivo retro- 
viral gene transfer to vascular cells. Demonstrating 
the importance of this relationship in vivo, balloon- 
injured rats infused with concentrated retrovirus in 
this study have shown successful gene transfer (Fig. 
.gN  
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k \ \ \ \ \ \ \ \ \ \ \ \~  
RSMC HIAEC 
Fig. 5. Rates of cell proliferation as measured by tritiated 
thymidine uptake. Cells were plated as described inFig. 2, 
but at the time ofretroviral exposure wells were incubated 
for 1 hour in 3H-thymidine (2 wCi/well). Trichloroacetic 
acid precipitable xtracts were subsequently counted in a 
J3-scintillation counter. Counts per minute were normal- 
ized to the number of cells present for each cell type. 
Results demonstrate the rate of proliferation of the 
RPAECs to be higher than that of RSMCs or HIAECs. 
Data are expressed as mean + SEM (n = 1 well) and are 
representative of three similar experiments. *p < 0.05 vs 
RSMCs, HIAECs. 
6, A and D), whereas those infused with lower titer, 
unconcentrated retrovirus in this study (Fig. 6, B and 
E) and other studies n have been unsuccessful. Al- 
though the level of gene transfer documented in this 
study may not be sufficient o achieve a concentra- 
tion of recombinant protein to have a biologic effect, 
this study represents progress in that direction. 
The mechanism by which retroviral concentra- 
tion affects TE during short incubations has not been 
defined completely. The concentration-dependent 
effect on TE corroborates current studies investigat- 
ing whether etroviral infection, and thus TE, is in 
part mediated by the RAM-1 retroviral recep- 
tor. 1,26,27 This receptor is an endogenous phosphate 
transporter found in most cell types, which has been 
shown to be used by the amphotropic MMLV to 
gain entry into the target cell. The RAM-1 receptor 
suggests a mechanism for the effect of concentration 
on TE seen in this study. By increasing the number 
of viable viral particles per cell (CFU/cell), available 
RAM-1 retroviral receptors become more saturated 
and thus increase the probability of retroviral incor- 
poration into the target cell. Studies have shown that 
cell types in different issues possess differing densi- 
ties of RAM-1 receptors 27 and that cells that possess 
very few receptors are not as transducible with an 
amphotropic MMLV as those "with many receptors.27 
Furthermore, it has recently been shown that efforts 
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Fig. 6. Histologic examination of perfusion-fixed balloon-injured rat carotid artery cross- 
sections 2 days after etroviral infusion (original magnification, 100x). A and B, Heat-stable 
alkaline phosphatase (purple) indicative of hpAP activity in neointimal cells (arrows) after 
infusion of concentrated or unconcentrated pLJhpAP retroviral supernatant, respectively, 2 
days after balloon injury. C, Hematoxylin-eosin taining after infusion of concentrated pLJh- 
pAP retroviral supernatant 2 days after balloon injury. D and E, Heat-stable alkaline phospha- 
tase (purple) indicative of hpAP activity in adventitia fter infusion of concentrated or uncon- 
centrated pLlhpAP retroviral supernatant, respectively, 4 days after balloon injury. F, 
Hematoxylin-eosin taining after infusion of concentrated pLJhpAP retroviral supernatant 4 
days after balloon injury. Controls for the vessel injury (infused with media and polybrene) 
tested negative for any hpAP activity (photos not shown). 
to increase the number of receptors on a given target 
cell can serve to elevate retroviral TE. 26 These stud- 
ies, combined with the present study's demonstra- 
tion that he difference in TE among cell types did 
not correlate only with respective proliferation rates, 
suggest that TE differences may be accounted for, in 
part, by the ratio of viable retroviral particles to 
RAM-1 receptors on the target cell's membrane. 
Strategies designed to increase the TE by means of 
upregulation of the RAM-1 receptor hold promise to 
further optimize direct, rctroviral-mediated gene 
transfer in vivo. 
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CONCLUSION 
This study demonstrates a trong relationship be- 
tween concentration and vascular cell TE during 
short, clinically feasible incubation periods. This rela- 
tionship is particularly important for direct rctroviral- 
mediated gene transfer in vivo to vascular cells be- 
cause of the TE attained during short incubation 
periods that are also feasible for vessel occlusion. The 
lack of correlation among TE of different ypes of 
vascular cells and their rates of proliferation suggests 
a limiting factor in addition to cell cycle for retrovi- 
ral-mediated gene transfer achieved uring short in- 
cubation periods. Future studies designed to upregu- 
late receptor-mediated rctroviral entry into the cell, 
combined with the advantage of elevating the con- 
cent_ration ofretroviral particles, point to new strate- 
gies of increasing vascular cell TE in vivo. 
We thank Dr. Blake Koessler for the pLJhpAP retrovi- 
ral producer cells. 
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